Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

3thpctl

Volume

0.32×avg

Market Cap

38.13MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on BioXcel Therapeutics, Inc.

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

BioXcel Therapeutics, Inc.

BTAINASDAQ Capital Market·USD·Closed

BioXcel Therapeutics, Inc.

BTAINASDAQ·USD·Closed

$1.24

+6.47%

$1.24

+$0.07 (6.47%)

52W Range

3thpctl

Volume

0.32×avg

Mkt Cap

38.13MUSD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

BTAI: BioXcel Therapeutics, Inc. Company Profile & Overview | finqOS